DNA repair mechanisms in the pathogenesis of hepatocellular carcinoma
DNA repair mechanisms in the pathogenesis of hepatocellular carcinoma
批准号:
nhmrc : 418100
负责人:
Prof Narcissus Teoh
金额:
$22.61万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Hepatocellular carcinoma (HCC) or cancer originating in the liver ranks 5th in worldwide frequency among tumours, and is the 3rd highest cause of cancer in our region. The incidence is increasing in most countries including Australia, Japan and USA. The overall prognosis is poor, with >80% affected persons dying from this disorder. The risk factors for HCC are well known and include chronic hepatitis B or C virus infection, alcoholism and liver iron accumulation. Despite the vast amount of information available regarding these risk factors, the way in which they alter normal liver cells to make them cancerous remains undefined. The majority of liver cancers, regardless of cause, develop in severely scarred, or cirrhotic liver in the presence of chronic liver inflammation. Such an environment causes liver cells, which are usually stable and not dividing, to continue replicating in response to injury; such continued cell division can lead to damaged genetic information in the DNA of these cells. Many cancers are associated with chromosomal damage, including broken ends and deleted genetic material. The main focus of this project to investigate how defective repair of disrupted genetic information contained in DNA of chromosomes in damaged liver cells contributes to the development of liver cancer. Using mice lacking specific genetic information to repair DNA double strand breaks, we plan to investigate whether abnormalities in DNA repair mechanisms in liver cells damaged by diethylnitrosamine (DEN) predisposes liver cells to regenerate abnormally thereby progressing to cancer. We have clues that 7 specific sites in chromosomes where loss of key genes may promote HCC formation. These studies will greatly enhance our understanding of the molecular basis by which HCC develops. The ultimate goal of this research is to develop effective screening and treatment strategies to prevent or interrupt the process of liver cancer development in at-risk individuals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
p53 and hepatocyte proliferation in chronic liver disease
-
批准号:nhmrc : 1059488
-
项目类别:Project Grants
-
资助金额:$22.1万
-
财政年份:2014
-
负责人:Prof Narcissus Teoh
-
依托单位:
Role of DNA repair mechanisms in the pathogenesis of hepatocellular carcinoma.
-
批准号:nhmrc : 262005
-
项目类别:Early Career Fellowships
-
资助金额:$14.53万
-
财政年份:2003
-
负责人:Prof Narcissus Teoh
-
依托单位:
Cellular mechanisms of hepatic ischaemia - reperfusion infusion
-
批准号:nhmrc : 997496
-
项目类别:NHMRC Postgraduate Scholarships
-
资助金额:$6.23万
-
财政年份:1999
-
负责人:Prof Narcissus Teoh
-
依托单位:
国内基金
海外基金
登录
查看更多内容
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
-
批准号:82371102
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:苏蕴
-
依托单位:
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
-
批准号:82371825
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:占贞贞
-
依托单位:
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
-
批准号:82370743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姜娜
-
依托单位:
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
-
批准号:82371585
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:周鲁明
-
依托单位:
槲皮素控释系统调控Mettl3/Per1修复氧化应激损伤促牙周炎骨再生及机制研究
-
批准号:82370921
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:徐袁瑾
-
依托单位:
解码精母细胞特异5’UTR元件调控DNA损伤修复基因MSH5翻译挽救减数分裂障碍的研究
-
批准号:82371607
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:李铮
-
依托单位:
运用3D打印和生物反应器构建仿生尿道模型探索Hippo-YAP信号通路调控尿道损伤修复的机制研究
-
批准号:82370684
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅强
-
依托单位:
铜募集微纳米网片上调LOX活性稳定胶原网络促进盆底修复的研究
-
批准号:82371638
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈信良
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
KLK10调控胶质—血管耦合与对话促缺血性卒中后血脑屏障修复的机制
-
批准号:82371465
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李龙宣
-
依托单位: